IFJPY yields 2.64% · PFE yields 6.13%● Live data
📍 IFJPY pulled ahead of the other in Year 1
Combined, IFJPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IFJPY + PFE for your $10,000?
Informa plc operates as an intelligence, events, and scholarly research company worldwide. It operates through five divisions: Informa Connect, Informa Intelligence, Informa Markets, Informa Tech, and Taylor & Francis. The Informa Connect division delivers specialist content and live experiences through in-person and virtual events, and digital platforms and services that enables businesses and professionals to meet, connect, learn, and share knowledge. This division operates events in the finance, biotech and pharma, and other specialist markets, including food and hospitality, marketing, and pop culture. The Informa Intelligence division offers critical data and specialist intelligence to businesses in the areas of pharma, finance, and maritime. The Informa Markets division connects buyers and sellers and supports the flow of business and trade in various specialist markets. Its major brands help businesses meet, discover products, trade and grow through major exhibitions, virtual events, digital marketplaces, and specialist content and data services. The Informa Tech division offers research, media, training, and events that inform, educate, and connect businesses and professionals working in technology. The Taylor & Francis division commissions, curates, produces, and publishes scholarly research and reference-led content in specialist subject areas, which assists to advance research and enabling knowledge to be discovered and shared. This segment houses teaching guides, videos, case studies, and approximately 18,000 book chapters and journal articles. The company was formerly known as T&F Informa plc and changed its name to Informa plc in August 2005. Informa plc was founded in 1998 and is headquartered in London, the United Kingdom.
Full IFJPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.